Atypical antipsychotic drugs and diabetes mellitus in the USFDA adverse event reporting system (AERS) database in pediatric and adult patients

被引：0
|
作者：
Doraiswamy, P. Murali [1 ,2 ]
Arani, Ramin A. [3 ]
Gan, David [3 ]
Pikalov, Andrei [4 ]
Tran, Quynh-Van [4 ]
Mankoski, Raymond [5 ]
Baker, Ross A. [5 ]
机构：
[1] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Bristol Myers Squibb Co, Hopewell Jct, NY USA
[4] Otsuka Amer Pharmaceut Inc, Rockville, MD USA
[5] Bristol Myers Squibb Co, Plainsboro, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2008年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
893
引用
收藏
页码：283S / 284S
页数：2
相关论文
共 50 条
  • [1] Detecting drugs that cause thrombocytopenia: A comparison of published case reports and data mining of the USFDA adverse event reporting system (AERS) database.
    Li, Xiaoning
    Terrell, Deirdra R.
    George, James N.
    Vesely, Sara K.
    [J]. BLOOD, 2006, 108 (11) : 140A - 141A
  • [2] Data mining in the USFDA adverse event reporting system (AERS): Depression/suicidality and unexpected adverse events with anti obesity drugs
    Patrick DeLisle, F.
    Hornbuckle, Kenneth
    Noel, Rebecca
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S21 - S21
  • [3] Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Elsa
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2017, 30 : 152 - 156
  • [4] Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
    Baker, Ross A.
    Pikalov, Andrei
    Tran, Quynh-Van
    Kremenets, Tatyana
    Arani, Ramin B.
    Doraiswamy, P. Murali
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (01) : 11 - 31
  • [5] EMPAGLIFLOZIN INDUCED PANCREATITIS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Sharma, V
    Viswam S, K.
    Ravindra, Reddy N.
    Chacko, S.
    Bellapu, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S592 - S593
  • [6] Vedolizumab associated haematochezia: A disproportionality analysis in USFDA adverse event reporting system database
    Bellapu, Anusha
    Viswam, Subeesh K.
    Sharma, Vasista
    Chacko, Stephy T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 464 - 464
  • [7] MEPOLIZUMAB INDUCED MYALGIA: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Chacko, S.
    Viswam, K. S.
    Reddy, Ravindra N.
    Sharma, V
    Bellapu, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S882 - S882
  • [8] BEVACIZUMAB INDUCED PULMONARY EMBOLISM: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Bellapu, A.
    Viswam, K. S.
    Reddy, Ravindra N.
    Chacko, S.
    Sharma, V
    [J]. VALUE IN HEALTH, 2019, 22 : S883 - S884
  • [9] POTENTIAL ASSOCIATION OF REMDESIVIR AND HYPERKALEMIA: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Das, A.
    Vajapu, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S172 - S172
  • [10] NOVEL ADVERSE EVENTS OF CGRP RECEPTOR ANTAGONISTS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Sangnure, A.
    Das, A.
    Sajjan, S.
    Ac, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S372 - S373
12345